SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001016504-14-000004
Filing Date
2014-02-13
Accepted
2014-02-13 11:34:03
Documents
7
Period of Report
2014-02-12

Document Format Files

Seq Description Document Type Size
1 inb10qa_20131231.htm 10-Q/A 33020
  Complete submission text file 0001016504-14-000004.txt   5574104

Data Files

Seq Description Document Type Size
2 inbp-20131231.xml EX-101.INS 1193314
3 inbp-20131231.xsd EX-101.SCH 42900
4 inbp-20131231_cal.xml EX-101.CAL 37609
5 inbp-20131231_def.xml EX-101.DEF 206676
6 inbp-20131231_lab.xml EX-101.LAB 292390
7 inbp-20131231_pre.xml EX-101.PRE 203407
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-31668 | Film No.: 14603945
SIC: 2834 Pharmaceutical Preparations